The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 01, 2020
Filed:
Aug. 06, 2018
Applicant:
Depuy Synthes Products, Inc., Raynham, MA (US);
Inventors:
Laura J. Brown, Hamilton Square, NJ (US);
Alexander M. Harmon, Clinton, NJ (US);
Anna Gosiewska, Skillman, NJ (US);
Assignee:
DePuy Synthes Products, Inc., Raynham, MA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 35/51 (2015.01); C12N 5/074 (2010.01); C12N 5/073 (2010.01); A61K 38/18 (2006.01); A61K 38/19 (2006.01); A61K 38/20 (2006.01); A61K 38/27 (2006.01); C12N 5/0735 (2010.01); A61K 35/50 (2015.01); A61K 35/12 (2015.01);
U.S. Cl.
CPC ...
A61K 35/51 (2013.01); A61K 35/50 (2013.01); A61K 38/18 (2013.01); A61K 38/185 (2013.01); A61K 38/1808 (2013.01); A61K 38/1825 (2013.01); A61K 38/1833 (2013.01); A61K 38/1841 (2013.01); A61K 38/1858 (2013.01); A61K 38/1866 (2013.01); A61K 38/1891 (2013.01); A61K 38/19 (2013.01); A61K 38/204 (2013.01); A61K 38/2053 (2013.01); A61K 38/27 (2013.01); C12N 5/0605 (2013.01); C12N 5/0606 (2013.01); C12N 5/0607 (2013.01); A61K 35/12 (2013.01); C12N 2500/32 (2013.01); C12N 2500/34 (2013.01); C12N 2500/44 (2013.01); C12N 2500/90 (2013.01); C12N 2500/95 (2013.01); C12N 2501/12 (2013.01); C12N 2501/21 (2013.01); C12N 2501/23 (2013.01); C12N 2502/02 (2013.01); C12N 2506/02 (2013.01); C12N 2506/03 (2013.01); C12N 2509/00 (2013.01); C12N 2533/50 (2013.01);
Abstract
Cells derived from postpartum tissue and products thereof having the potential to support cells of and/or differentiate to cells of a soft tissue lineage, and methods of preparation and use of those postpartum tissue-derived cells, are provided by the invention. The invention also provides methods for the use of such postpartum-derived cells and products related thereto in therapies for conditions of soft tissue.